A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease
- Submitting institution
-
Swansea University / Prifysgol Abertawe
- Unit of assessment
- 12 - Engineering
- Output identifier
- 26822
- Type
- D - Journal article
- DOI
-
10.1021/acs.molpharmaceut.5b00794
- Title of journal
- Molecular Pharmaceutics
- Article number
- -
- First page
- 863
- Volume
- 13
- Issue
- 3
- ISSN
- 1543-8384
- Open access status
- Out of scope for open access requirements
- Month of publication
- February
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
-
- Research group(s)
-
4 - SPEC - Systems and Process Engineering Centre
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- The research detailed in the paper helped to secure £6,000,000 of investment to develop the drug and undertake clinical trials from Innovate UK funding (IUK Ref 132175).
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
